Updated hourlyHourly refreshTue, Sep 8, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
(PR-inside.com) NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / August 31, 2026 / Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE:LOBE)(OTCQB:LOBEF)(Frankfurt:LOBE.F), a clinical-stage biopharmaceutical company advancing therapeutic development programs through focused subsidiary companies, is pleased to announce closing of the second tranche of its previously announced non-brokered private placement offering of common shares in the capital of the Company ("Common Shares") at a price of $0.085 per Common Share (the "Private Placement"). The Company closed the first tranche of the Private Placement on August 19, 2026 (the "First Tranche") through the ..
Aug 31 · 23:00·PR-Inside
Healthcare
(PR-inside.com) "DEA's New Questionnaire Exposes a Federal Marijuana System Built on State Rules, Special Exceptions and Questions No One Can Answer Cleanly", stated Duane Boise CEO MMJ International Holdings. WASHINGTON, D.C. / ACCESS Newswire / August 31, 2026 / The marijuana industry celebrated Schedule III as federal recognition. Now federal recognition has arrived carrying a clipboard. BE CAREFUL WHAT YOU WISH FOR A 26-question Drug Enforcement Administration follow-up form obtained by Marijuana Moment asks state marijuana operators to identify their suppliers, laboratories, employees, inventory systems, interstate plans, security controls, patient-verification procedures and methods for destroying moldy, insect-infested or expired marijuana. This is where the political ..
Aug 31 · 22:45·PR-Inside
Healthcare
Toronto, Ontario--(Newsfile Corp. - August 31, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") today announced its financial results for the three and nine-month periods ended June 30, 2026 ("Q3 Fiscal 2026"). The Company's condensed interim consolidated financial statements and related management's discussion and analysis for the period (collectively, the "Interim Filings") have been filed under the Company's profile on SEDAR+ at...
Aug 31 · 22:37·mlpr-newsfile
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 31, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
Aug 31 · 22:30·PR-Inside
Healthcare
Konstantin Vision & Eyewear Center in New York details its in-house fitting process for designer frames, covering measurements, alignment and on-site adjustments.
Aug 31 · 22:10·PressReleaseNews
Healthcare
Dual Restoration, a Brooklyn-based restoration firm, has launched a dedicated 24/7 biohazard cleanup company service for healthcare facilities managing infection and contamination risks.
Aug 31 · 22:10·PressReleaseNews
Healthcare
Cult Australian suncare brand debuts Unblock Screen™ SPF 50, the first US sunscreen formulated with Bemotrizinol (BEMT), approved by the FDA in June 2026 NEW YORK, Aug. 31, 2026 /PRNewswire/ -- Ultra Violette, the cult Australian suncare brand known for pairing high-performance SPF with...
Aug 31 · 22:06·PR Newswire
Finance · Healthcare
BURLINGAME, Calif., Aug. 31, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that the Company will present data from...
Aug 31 · 22:05·PR Newswire
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 31, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Aug 31 · 22:02·PR-Inside
Finance · SaaS
MENLO PARK, Calif., August 31, 2026--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that four abstracts highlighting clinical and nonclinical data supporting the development of epetraborole, a novel boron-containing oral candidate for the treatment of polycythemia vera (PV), will be presented at the Society of Hematologic Onco
Aug 31 · 22:00·mlpr-businesswire
Healthcare
– Agreement supports commitment to patient access, affordability and innovation – TOKYO, Aug. 31, 2026 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has reached an agreement with the U.S. government that reflects our...
Aug 31 · 22:00·PR Newswire
Finance · Healthcare
WATERTOWN, Mass., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from multiple clinical programs, including an oral presentation of initial data from the RESTORE-PV trial of DISC-3405 in patients with polycythemia vera (PV), at the SOHO Annual Meeting, which will be held in Houston, Texas on September 9-12, 2026.
Aug 31 · 22:00·GlobeNewswire